Lupin receives USFDA approval to market Tobi in US
Lupin has received final USFDA approval to market a generic version of Novartis’ inhalation product Tobi, which is used to treat cystic fibrosis, in the […]
Month: May 2017
Unichem Laboratories receives USFDA approval for Piroxicam
Unichem Laboratories has received final USFDA approval for Piroxicam capsules, used in the treatment of osteoarthritis and rheumatoid arthritis, in the US market. The approved […]
Alembic Pharma receives USFDA approval for fenofibric acid delayed release capsules
Alembic Pharmaceuticals has received final USFDA approval for Fenofibric acid delayed-release capsules used for lowering high cholesterol and increasing good cholesterol. The approved product is […]
Strides Shasun to expand its Kudikadu plant
Strides Shasun is planning to expand its pharmaceutical plant in Kudikadu in SIPCOT in Cuddalore district of Tamil Nadu. The project involves expanding the manufacturing […]
Natco Pharma to expand its Mekaguda plant
Natco Pharma is planning to expand its Mekaguda plant in Ranga Reddy district of Telangana with an investment of Rs. 4800 million. The project involves […]
Alembic receives USFDA approval for olmesartan and hydrochlorothiazide
Alembic Pharmaceuticals has received final USFDA approval for two anti-hypertension tablets – olmesartan medoxomil tablets, 5 mg, 20 mg, and 40 mg and olmesartan medoxomil […]